A
Absci Corporation (ABSI)
NMS – Real Time Price. Currency in USD
5.36
-0.42 (-7.35%)
At close: May 12, 2026, 4:00 PM EDT
5.48
+0.13 (2.40%)
Pre-market: May 13, 2026, 8:24 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
5.36
-0.42 (-7.35%)
At close: May 12, 2026, 4:00 PM EDT
5.48
+0.13 (2.40%)
Pre-market: May 13, 2026, 8:24 AM EDT
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
| Name | Position |
|---|---|
| Amir Shanehsazzadeh | Chief AI Officer |
| Dr. Christine Lemke D.V.M., M.B.A., Ph.D. | Senior Vice President of Portfolio & Growth Strategy |
| Dr. Ransi Somaratne FACC, M.B.A., M.D. | Chief Medical Officer |
| Dr. Zachariah Jonasson Ph.D. | Chief Business Officer & CFO |
| Mr. Alexander Khan CPA | CVP of Finance & Head of Investor Relations |
| Mr. Sean McClain | Founder, CEO, President & Director |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | absc-20260507.htm |
| 2026-05-07 | 10-Q | absi-20260331.htm |
| 2026-04-22 | DEFA14A | proxyadditionalmaterials20.htm |
| 2026-03-24 | S-8 | s-8x2026x03x2026evergreeni.htm |
| 2026-03-06 | 8-K | absc-20260303.htm |
| 2026-01-14 | 8-K | absc-20260114.htm |
| 2025-11-12 | 8-K | absc-20251112.htm |
| 2025-11-12 | 10-Q | absi-20250930.htm |
| 2025-11-04 | 8-K | absc-20251031.htm |
| 2025-08-20 | CORRESP | filename1.htm |
| Mr. Todd Bedrick CPA | Senior VP & Chief Accounting Officer |
| Mr. Wen Sha | Chief of Staff |
| Ms. Jeanne Schreuder M.B.A., SPHR | Senior Vice President of People & Experience |
| Ms. Shelby Walker J.D. | Chief Legal Officer |